Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort-Reference-Cited by-同舟云学术

Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort

Published:2024-03 Issue: Volume:105 Page:102820
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Maruyama Yumiko,Nishikii Hidekazu,Kurita Naoki,Sakamoto Tatsuhiro,Hattori Keiichiro,Suehara Yasuhito,Yokoyama Yasuhisa,Kato Takayasu,Obara Naoshi,Sakata-Yanagimoto Mamiko,Chiba Shigeru

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference35 articles.

1. Modern approaches to HLA-haploidentical blood or marrow transplantation;Kanakry;Nat. Rev. Clin. Oncol.,2016

2. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report;Passweg;Bone Marrow Transplant.,2017

3. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant;Ruggeri;Haematologica,2017

4. Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide;Munchel;Best Pract. Res. Clin. Haematol.,2011

5. Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide;Castagna;Biol. Blood Marrow Transplant.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics;Advances in Pharmacological and Pharmaceutical Sciences;2024-01